The transcription factor p53 can induce growth arrest or death in cells. Tumor cells that develop mutations in p53 demonstrate a diminished apoptotic potential, which may contribute to growth and tumor metastasis. Cellular levels of p53 are stabilized during hypoxia. The present study tested the hypothesis that reactive oxygen species (ROS) released from mitochondria regulate the cytosolic redox state and are required for the stabilization of p53 protein levels in response to hypoxia. Our results indicate that hypoxia (1.5% O 2 ) increases mitochondrial ROS generation and increases p53 protein levels in human breast carcinoma MCF-7 cells and in normal human diploid ®broblast IMR-90 cells. MCF-7 cells depleted of their mitochondrial DNA (r8 cells) failed to stabilize p53 protein levels during hypoxia. The antioxidant Nacetylcysteine and the Cu/Zn superoxide dismutase inhibitor diethyldithiocarbamic acid abolished the hypoxia-induced increases in ROS and p53 levels. Rotenone, an inhibitor of mitochondrial complex I, and 4,4'-diisothiocyanato-stilbene-2,2'-disulfonate, a mitochondrial anion channel inhibitor, also abolished the increase in ROS signal and p53 levels during hypoxia. The p53-dependent gene p21 WAF1/CIP1 was also induced by hypoxia in both MCF-7 and IMR-90 cells without aecting the growth rate of either cell line. In contrast, both cell lines exhibited increases in p21 WAF1/CIP1 expression and growth arrest after gamma irradiation. Primary chick cardiac myocytes and murine embryonic ®broblasts also showed an increase in p53 protein levels in response to hypoxia without cell death or growth arrest. These results indicate that mitochondria regulate p53 protein levels during hypoxia through a redox-dependent mechanism involving ROS. Despite p53-induction, hypoxia alone does not cause either growth arrest or cell death.
Introduction
In malignant tumors, regions of hypoxia develop when the rate of cell growth and metabolism exceeds the supply of oxygen provided by new blood vessel formation (angiogenesis). Consequently, many tumor cells survive under chronically or transiently low environmental oxygen conditions. Hypoxic cells within tumors respond (a) by transcriptionally upregulating glucose transporters and glycolytic enzymes to compensate for the decrease in the oxidative capacity to generate ATP, and (b) by releasing factors such as vascular endothelial growth factor (VEGF) that promote angiogenesis (Dang and Semenza, 1999) . However, under conditions of severe hypoxic stress, cell proliferation can become inhibited and cell death may ensue. The p53 tumor suppressor protein is a potent transcription factor that can activate target genes that initiate cell death, or cause growth arrest in response to stress or DNA damage (Giaccia and Kastan, 1998) . Among the gene products potentially induced by p53 is p21 WAF1/CIP1 , an inhibitor of cyclindependent kinase that can initiate cell cycle arrest (Harper et al., 1993; el-Deiry et al., 1993) . Hypoxia induces the stabilization of p53 protein levels (Graeber et al., 1994) . Hypoxia-induced cell death may function as an important safeguard against tumor development (Graeber et al., 1996; Kinzler and Vogelstein, 1996) . Mutations in p53 promote tumor cell growth and survival by allowing cells to avoid hypoxia-induced growth arrest and cell death. Indeed, the elimination of a functional p53 is the most common genetic defect observed in human solid tumors (Hollstein et al., 1991) . Despite the progress in understanding the functional role of p53 in tumorigenesis, the mechanisms underlying the stabilization of p53 during hypoxia are not well understood.
Recently, a variety of mechanisms have been proposed to explain the induction of transcriptionally active wild-type p53 during hypoxia, including a requirement for acidosis (Schmaltz et al., 1998) , and a concomitant stabilization of the transcription factor hypoxia inducible factor 1, HIF-1 Carmeliet et al., 1998) . The hypoxia-induced stabilization of transcription factors including p53 and HIF-1 can also be mimicked by incubation with the transition metal cobalt under normoxic conditions . Although no consensus exists regarding the mechanism by which either hypoxia or cobalt ions activate the transcription process, current theory on hypoxic signaling relies on reactive oxygen species (ROS) as mediators of hypoxia-induced gene transcription (Semenza, 1999) . In this regard, there is controversy in the literature whether an increase or a decrease in ROS production is required for hypoxic signaling. One current theory postulates reduced levels of ROS trigger the transcriptional response during hypoxia (Bunn and Poyton, 1996 ). An alternative model suggests that an increase in mitochondrialdependent ROS production is primarily responsible for the hypoxia-induced gene transcription ).
The present study evaluated the role of ROS production on p53 protein stabilization during hypoxia (1.5% O 2 ). Our results indicate that p53 accumulation during hypoxia requires an increase in a mitochondriadependent ROS signal in both human breast carcinoma MCF-7 cells and in human diploid ®broblast IMR-90 cells. We also investigated whether cells undergoing hypoxia-induced p53 activation exhibited growth arrest and/or cell death. Surprisingly, neither cell type underwent growth arrest or cell death during hypoxia, although both cell types were capable of demonstrating those responses after gamma irradiation.
Results

Hypoxia increases mitochondrial generation of reactive oxygen species
Both hypoxia and cobalt chloride can activate redox signaling in human hepatoma Hep3B cells and chick embryonic cardiac myocytes by accelerating the production of reactive oxygen species Duranteau et al., 1998) . To demonstrate this in human breast carcinoma MCF-7 cells, these cells were incubated with the non¯uorescent probe, 2',7'-dichloro¯uorescin, (DCFH-DA) (Bass et al., 1983) . This probe enters the cells and can be oxidized in the presence of ROS, generating the¯uorescent compound, 2',7', dichloro¯uorescein (DCF). Previous studies have indicated that the DCFH probe is sensitive to oxidation by H 2 O 2 , but not by superoxide (Carter et al., 1994) . MCF-7 cells exposed for 8 h to hypoxia (1.5% O 2 ), or to cobalt chloride (100 mM) during normoxia, demonstrated an increase in DCF¯uores-cence (Figure 1a,b) . During oxidative phosphorylation, superoxide can be generated as a result of electron¯ux through complex III (Turrens et al., 1985) . To determine the role of mitochondrial ROS in the response to hypoxia, MCF-7 cells were incubated with rotenone, an inhibitor of electron transport that acts at complex I upstream of the site of mitochondrial ROS generation. The increase in DCF signal observed during hypoxia was abolished in the presence of rotenone (Figure 1a ). By contrast, rotenone failed to abolish the increase in DCF¯uorescence elicited by cobalt chloride (Figure 1b) . Superoxide generated within mitochondria is normally converted to hydrogen peroxide (H 2 O 2 ) by the manganese superoxide dismutase (SOD) located in the matrix. This H 2 O 2 is subsequently degraded by the mitochondrial glutathione peroxidase system. Alternatively, mitochondrial superoxide may enter the cytosol via anion channels (Takahashi and Asada, 1983) , where it can be converted to H 2 O 2 by the cytosolic Cu/Zn SOD. Anion channels have been described in both the inner and outer mitochondrial membranes (Ballarin and Sorgato, 1996; Colombini et al., 1996) . An inhibitor of these channels such as 4,4'-diisothiocyanato-stilbene-2,2'-disulfonate (DIDS) can suppress the egress of superoxide from the mitochondria (Beavis et al., 1996) . Figure 1a shows that DIDS abolished the increase in DCF¯uorescence observed during hypoxia. By contrast, DIDS failed to attenuate the cobalt chloridestimulated increase in the DCF signal (Figure 1b) , which is consistent with the conclusion that hypoxia augments mitochondrial ROS signaling while cobalt chloride augments non-mitochondrial cytosolic ROS generation.
To con®rm that H 2 O 2 was responsible for the cytosolic oxidation of DCFH during hypoxia or cobalt chloride, MCF-7 cells were incubated with the antioxidant N-acetylcysteine (NAC) or the cytosolic Cu-Zn superoxide dismutase inhibitor diethyldithiocarbamic acid (DDC) during hypoxia or cobalt chloride incubation (Misra, 1979) . In the presence of DDC, cytosolic SOD activity is inhibited and the rate of cytosolic H 2 O 2 formation is attenuated. N-acetylcysteine is a thiol reductant that repletes cytosolic reduced glutathione levels, thereby enhancing the rate of H 2 O 2 scavenging (Miners et al., 1984) . In accordance with this, the increase in DCF¯uorescence in response to hypoxia or to cobalt chloride was abolished in the presence of the antioxidant NAC and the SOD inhibitor (Figure 1a,b) . These results support the conclusion that H 2 O 2 generated in the cytosol from Figure 1 Eect of hypoxia and cobalt chloride on ROS generation. ROS generation in cells was assessed using the probe 2',7'-dichloro¯uorescein diacetate (DCFH-DA) (Molecular Probes). ROS in the cells oxidize DCFH, yielding the¯uorescent product 2',7'-dichloro¯uorescein (DCF). Data are normalized to normoxic untreated samples. The following reagents were used: 4,4'-diisothiocyanato-stilbene-2,2'-disulfonate (DIDS, 150 mM), a mitochondrial anion channel blocker; diethyldithiocarbamic acid (DDC, 1 mM), a cytosolic superoxide dismutase inhibitor; N-acetylcysteine (NAC, 1 mM), an antioxidant; and rotenone (ROT, 1 mg/ml), a mitochondrial complex I inhibitor. (a) DCF¯uorescence in MCF-7 cells exposed to 21% O 2 , and 1.5% O 2 in the presence of inhibitors. (b) DCF¯uorescence in MCF-7 cells exposed to 21% O 2 and 21% O 2 +cobalt chloride (100 mM) in the presence of inhibitors mitochondrial superoxide is responsible for the DCFH oxidation observed during hypoxia, and that H 2 O 2 generated from a non-mitochondrial source is responsible for DCFH oxidation during normoxic cobalt chloride treatment.
Stabilization of p53 during hypoxia requires an increase in mitochondrial ROS
ROS have been implicated as participants in the signaling pathways involved in the activation of multiple transcription factors (Finkel, 1998) . To test whether mitochondrial ROS generation during hypoxia can regulate the hypoxic stabilization of p53, p53 protein levels were assessed in nuclear extracts from MCF-7 cells exposed to hypoxia, or cobalt chloride during normoxia. MCF-7 cells incubated under 1.5% O 2 or cobalt chloride (100 mM) for 8 h displayed an accumulation of p53 protein (Figure 2a ). To determine the dependence of the hypoxic response on mitochondrial ROS production, MCF-7 cells were exposed to hypoxia or cobalt chloride during normoxia for 8 h in the presence of rotenone and DIDS. Rotenone and DIDS both abolished the accumulation of p53 during hypoxia, but not during normoxic cobalt chloride treatment (Figure 2b, c) . To distinguish the relative importance of superoxide versus H 2 O 2 as the active signaling element required for the accumulation of p53, DDC and NAC were incubated in the presence of hypoxia or cobalt chloride for 8 h. Hypoxia or cobalt chloride-induced p53 levels were abolished in the presence of the DDC and NAC, indicating that H 2 O 2 production is required for accumulation of p53 under hypoxia or cobalt chloride (Figure 2c, d) .
Hypoxic stabilization of p53 was also examined in MCF-7 cells depleted of mitochondrial DNA (r8-MCF-7 cells) which are respiration-incompetent. p53 protein levels were not induced in r8-MCF-7 cells exposed to hypoxia (Figure 3a) . However, r8-MCF-7 cells were still able to stabilize p53 protein levels in response to gamma radiation. To further assess the p53 response of MCF-7 cells during hypoxia or cobalt chloride, we examined p53 DNA binding activity using an electrophoretic mobility shift assay. Nuclear extracts prepared from MCF-7 cells exposed to hypoxia (1.5% O 2 ) or CoCl 2 (100 mM) for 8 h contained a protein complex capable of binding a DNA probe containing a p53 binding site (Figure 3b ). Rotenone and DIDS were able to abolish p53 DNA-binding activity during hypoxia but not during cobalt chloride treatment, while NAC and DDC abolished p53 DNA binding activity in cells exposed either to hypoxia or cobalt chloride. These results further support the hypothesis that reactive oxygen species generated by mitochondria are required for activation of p53 during hypoxia, that non-mitochondrial ROS are involved in the response to cobalt chloride, and that H 2 O 2 is the likely active ROS element required in both cases.
Cancer cells dier from normal cells with respect to their metabolic regulation (Warburg, 1956) . To determine whether the responses to hypoxia in MCF-7 cells were a consequence of their transformed state, we examined the p53 response to hypoxia in Figure 2 p53 protein levels in nuclear extracts from MCF-7 cells. (a) p53 protein levels were assessed in MCF-7 cells exposed to normoxia (21% O 2 ), hypoxia (1.5% O 2 ), or cobalt chloride (100 mM) for 8 h. (b) p53 protein levels were assessed in MCF-7 cells exposed to hypoxia (1.5% O 2 ) or cobalt chloride (100 mM) in the presence of the mitochondrial complex I inhibitor rotenone (1 mg/ml) for 8 h. (c) p53 protein levels were assessed in MCF-7 cells exposed to hypoxia (1.5% O 2 ) or cobalt chloride (100 mM) in the presence of the mitochondrial anion channel inhibitor DIDS (150 mM), or the cytosolic superoxide dismutase inhibitor DDC (1 mM) for 8 h. (d) p53 protein levels were assessed in MCF-7 cells exposed to hypoxia (1.5% O 2 ) or cobalt chloride (100 mM) in the presence of the antioxidant NAC (1 mM) for 8 h Figure 3 (a) p53 protein levels were assessed in wild-type MCF-7 cells and r8-MCF-7 cells exposed to normoxia (21% O 2 ), hypoxia (1.5% O 2 ) and 400 rad. (b) p53 DNA binding activity in nuclear extracts from MCF-7 cells exposed to hypoxia (1.5% O 2 ) or to CoCl 2 (100 mM) during normoxia in the presence of a mitochondrial anion channel inhibitor, DIDS (150 mM); a cytosolic superoxide dismutase inhibitor, DDC (1 mM); the antioxidant, NAC (1 mM); and a mitochondrial complex I inhibitor, rotenone (1 mg/ml) for 8 h diploid ®broblast IMR-90 cells, an immortalized cell line. As shown in Figure 4 , rotenone and DIDS each abolished the p53 accumulation during hypoxia indicating that the mitochondrial electron transport chain again was the source of ROS responsible for the hypoxic stabilization of p53 protein levels. The antioxidant NAC and the SOD inhibitor DDC also abolished the p53 accumulation during hypoxia, suggesting that H 2 O 2 is the likely ROS required for the increase in p53 protein levels during hypoxia. Collectively, these results indicate that multiple cell types require an increased generation of superoxide from mitochondria that becomes H 2 O 2 in the cytosol during the hypoxia-induced stabilization of p53.
Hypoxia alone does not induce growth arrest or cell death
Physiological consequences of p53 stabilization in MCF-7 cells were assessed by measuring p21 protein levels, cell cycle regulation, and cell proliferation rates during hypoxia or in the presence of cobalt chloride during normoxia. Figure 5a shows that hypoxia and cobalt chloride both induced an increased in p21 protein levels compared to normoxic controls. However no detectable growth arrest or suppression of proliferation was seen with either intervention (Figure 5b, c) . To determine whether the p53/p21 growth arrest response is functional in MCF-7 cells, cell cycle analysis was assessed in control MCF-7 cells and in E6 protein-expressing MCF-7 cells exposed to gamma irradiation. The E6 protein is a product of the human papillomavirus that enhances p53 degradation by the ubiquitin pathway (Schener et al., 1990) . MCF-7 cells exposed to gamma irradiation at a concentration of 400 rad stabilized p53 and demonstrated subsequent expression of p21, while MCF-7/E6 cells failed to demonstrate that response (Figure 6a,b) . Moreover, control MCF-7 cells exposed to 400 rad exhibited G1 growth arrest and a decreased number of cells in S phase. By contrast, G2 growth arrest and no signi®cant change in S phase was noted in MCF-7/E6 cells following exposure to 400 rad as expected in p53-independent radiation-induced growth arrest. (Figure  6c ). To test whether p53 protein levels induced during hypoxia are insucient to induce growth arrest, functional consequences were determined in MCF-7 cells exposed to hypoxia and radiation under conditions where the levels of p53 were equal. Figure 6d shows that a dose of 100 rad elicits a similar degree of p53 induction as hypoxia. However, 100 rad did not cause growth arrest or cell death (data not shown). Analyses of cell cycle and p21 expression were also carried out in IMR-90 cells in response to hypoxia and gamma irradiation. Figure 7a ,b shows that p53 stabilization and p21 expression increased in response to hypoxia or gamma irradiation in IMR-90 cells. Hypoxia failed to cause growth arrest or a decrease in the cell proliferation rate (Figure 7c,d ) whereas gamma irradiation did induce growth arrest (Figure 7e) .
Previous reports have suggested that p53 participates in the initiation of cell death of primary dierentiated cells and murine embryonic ®broblasts in response to low oxygen conditions (Banasiak et al., 1998; Graeber et al., 1996) . The functional eects of hypoxia on murine embryonic ®broblasts and primary cultures of dierentiated embryonic chick cardiac myocytes were therefore examined. Murine embryonic ®broblasts increased p53 protein levels during hypoxia yet they Figure 4 p53 protein levels in nuclear extracts from the normal human diploid ®broblast IMR-90 cells exposed to normoxia (21% O 2 ) or hypoxia (1.5% O 2 ) in the presence of a cytosolic superoxide dismutase inhibitor, DDC (1 mM), a mitochondrial anion channel inhibitor (DIDS, 150 mM), an antioxidant NAC (1 mM), and a mitochondrial complex I inhibitor, rotenone (1 mg/ ml) for 8 h Figure 5 (a) p21 protein levels in nuclear extracts from MCF-7 cells. p21 protein levels were assessed in MCF-7 cells exposed to normoxia (21% O 2 ), hypoxia (1.5% O 2 ) or CoCl 2 (100 mM) for 18 h. (b) Representative analysis of cell cycle distribution as determined by DNA content. MCF-7 cells were exposed to normoxia (21% O 2 ), hypoxia (1.5% O 2 ) or CoCl 2 (100 mM) for 36 h. Cells in S phase normoxia: 7.2+2.1, hypoxia: 8.9+1.5, cobalt chloride: 8.3+1.7 (n=3). (c) Cell number was determined using a hemacytometer and cell viability was assessed by using Trypan blue Oncogene Redox regulation of p53 during hypoxia NS Chandel et al Figure 6 (a,b) p53 and p21 protein levels in nuclear extracts from MCF-7 cells exposed to normoxia (21% O 2 ), hypoxia (1.5% O 2 ), and gamma radiation (400 rad) or MCF-7 cells containing the E6 protein. p53 and p21 protein levels were analysed after 8 and 18 h of treatment respectively. (c) Representative cell cycle analysis of Neo/MCF-7 cells and MCF-7/E6 clones exposed to gamma radiation (400 rad). Cells in S phase Neo/Ctrl: 8.9+1.6, Neo/400 rad: 2.7+1.9, E6/Ctrl: 11.4+3.1, E6/400 rad: 9.7+2.3 (n=3). (d) p53 protein levels in nuclear extracts from MCF-7 cells exposed to normoxia (21% O 2 ), hypoxia (1.5% O 2 ), and gamma radiation (100 or 400 rad) Figure 7 (a) p53 protein levels in nuclear extracts from IMR-90 cells analysed after 8 h of exposure to normoxia (21% O 2 ), hypoxia (1.5% O 2 ), and gamma radiation (400 rad). (b) p21 protein levels in nuclear extracts from IMR-90 cells analysed after 18 h of exposure to normoxia (21% O 2 ), hypoxia (1.5% O 2 ), and gamma radiation (400 rad). (c) Cell cycle distribution was determined by DNA content. IMR-90 cells were exposed to normoxia (21% O 2 ) or hypoxia (1.5% O 2 ) for 36 h. (d) Cell number was determined using a hemacytometer and cell viability was assessed by using Trypan blue. (e) Cell cycle analysis of IMR-90 cells exposed to gamma radiation (400 rad) failed to exhibit growth arrest (Figure 8) . Chick cardiac myocytes demonstrate spontaneous and synchronous contractions and exhibit an increase in ROS generation during hypoxia (Duranteau et al., 1998) . Yet these cells also failed to show a signi®cant increase in cell death after 48 h of hypoxia despite an increase in p53 protein levels ( Figure 9 ). These results suggest that hypoxia alone does not result in cell death or growth arrest in primary dierentiated cells, murine embryonic ®bro-blasts, tumor cells, or immortalized cell lines.
Discussion
Mitochondria regulate the stabilization of p53 protein levels during hypoxia by generating ROS that create an oxidizing signal in the cytosol. Evidence for mitochondrial redox regulation of p53 during hypoxia rests on the following observations. First, hypoxia-induced stabilization of p53 protein levels was not observed in r8 cells. These results indicate that an active respiratory chain is required for signaling of hypoxic stabilization of p53. Previous studies have reported that mitochondrial Complex III can function as an important site of superoxide generation (Turrens et al., 1985) . Electron transport inhibitors that act upstream of that site prohibit the entry of electrons, and thereby diminish superoxide generation. The speci®c mitochondrial complex I inhibitor rotenone abolished the increase in DCF¯uorescence and the increase in p53 protein levels during hypoxia. Cobalt chloride treatment during normoxia also augmented ROS generation in MCF-7 cells, and produced a stabilization of p53. However, the generation of ROS by cobalt chloride did not require mitochondrial electron transport and was not inhibited by rotenone. The ability of cobalt chloride to increase p53 protein levels in the presence of rotenone further indicates that secondary toxic eects of rotenone such as ATP depletion or loss of mitochondrial membrane potential could not have been responsible for its suppression of p53 protein levels observed during hypoxia. These results indicate that hypoxia causes ROS generation at a site distal to Complex I whereas cobalt chloride generates ROS by a Figure 9 (a) p53 protein levels in nuclear extracts from chick cardiac myocytes exposed to normoxia (21% O 2 ), hypoxia (1.5% O 2 ). (b) Cardiac myocytes were incubated for 48 h under normoxia (13.5%+3.43 cell death) or hypoxia (17.80+3.77) and cell death was assessed with P.I. (P=N.S., n=4) . Percentage of cell death was calculated based upon P.I. staining observed after administering Triton X-100 (0.5%) to ensure 100% cell death Figure 8 (a) p53 protein levels in nuclear extracts from murine embryonic ®broblasts (MEFs) exposed to normoxia (21% O 2 ), hypoxia (1.5% O 2 ). (b) Cell cycle distribution was determined by DNA content. MEFs were exposed to normoxia (21% O 2 ) or hypoxia (1.5% O 2 ) for 36 h. (c) Cell number was determined using a hemacytometer and cell viability was assessed by using Trypan blue distinct mechanism that is independent of the proximal mitochondrial electron transport system.
A growing number of studies indicate that low levels of ROS contribute importantly to a variety of intracellular signaling pathways. However, studies have also demonstrated that ROS can play a destructive role in pathophysiologic conditions such as ischemia and reperfusion injury. Vanden Hoek et al. (1998) found that low levels of mitochondrial ROS generated during a brief period of hypoxia were responsible for initiating the signal transduction system involved in`ischemic preconditioning' in a cardiomyocyte model of ischemia-reperfusion. By contrast, much higher levels of ROS were generated at the start of reperfusion, which were responsible for contractile dysfunction and cell death. In the present study we found that cells continued to proliferate during hypoxia, indicating that the signaling levels of ROS generated during hypoxia apparently were well tolerated. Collectively, these observations suggest that the magnitude of the oxidant signal and the intracellular loci involved in the oxidant stress are important for determining the eectiveness of signal transduction versus the initiation of cell injury.
Our observation that neither the tumorigenic MCF-7 cells nor the non-tumorigenic IMR-90 cells exhibited growth arrest after p53 stabilization and p21 protein expression indicates that the p53 pathway is tightly regulated during hypoxia. In response to gamma irradiation, both cell lines were capable of demonstrating increases in p53 and p21 protein levels and growth arrest indicating that a functional p53 pathway existed in both cell types. Protein levels of p53 were similar at 100 rad and during hypoxia and neither stimulus induced growth arrest. In contrast, a higher dose of gamma radiation (400 rad) elicited higher p53 protein levels and induced growth arrest suggesting that a threshold of p53 protein levels may exist, below which neither growth arrest nor cell death can occur. Normal embryonic ®broblasts did not undergo growth arrest during hypoxia and the embryonic chick cardiac myocytes did not undergo cell death during hypoxia. These results indicate that physiological hypoxia is not sucient to induce growth arrest or cell death, although it signi®cantly induces low levels of p53.
The results of this study suggest that induction of p53 can be uncoupled from eects on growth arrest and cell death. Why is p53 stabilized during physiological hypoxia? Normally, O 2 supply becomes limiting for electron transport and the rate of oxidative ATP synthesis below 0.5% O 2 because diusion of O 2 to the mitochondria begins to limit cytochrome c oxidase catalytic function (Wilson et al., 1979; Jones and Mason, 1978) . Above this critical O 2 concentration cells are able to generate sucient ATP via oxidative phosphorylation, yet the transcription factor HIF-1 is stabilized in the range of 0.5 ± 5.0% O 2 leading to the release of VEGF to promote angiogenesis (Jiang et al., 1996) . The HIF-1 mediated VEGF response may be anticipatory, preventing cells from becoming deprived of glucose, oxygen, and survival factors. However, if blood supply does not adequately match cellular proliferation rate then conditions may develop where cell death would occur due to a lack of O 2 , glucose, or survival factors. Interestingly, in a rapidly growing tumor this condition could provide a selective pressure for cells to overcome cell death. Thus, hypoxiaactivated p53 would lower the apoptotic threshold and prevent adaptation to conditions of substrate deprivation or loss of survival factors. In this regard, Giaccia and colleagues have observed p53-dependent apoptosis in oncogenically transformed cells at O 2 concentrations of 0.2% (Graeber et al., 1996) . Furthermore, Fisher and colleagues demonstrated that the p53-dependent cell death in oncogenically transformed cells at anoxia could be coupled to the development of acidosis (Schmaltz et al., 1998) . This suggests that multiple factors may be required for p53 initiation of apoptosis during hypoxia. Mutations in p53 could prolong survival of oncogenically transformed cells during anoxia and allow them to adapt to conditions with decreased survival factors and substrates until persistence of the HIF-1 mediated VEGF response would foster development of new blood vessels to replenish oxygen and nutrients. Another potential role of p53 during hypoxia is directly regulating tumor angiogenesis. Recently it has been demonstrated that genetic inactivation of p53 in cancer cells provides a potent stimulus for tumor angiogenesis (Ravi et al., 2000) . The loss of p53 enhances hypoxiainduced HIF-1 levels and augments HIF-1-dependent expression of VEGF in tumor cells. These ®ndings indicate that inactivation of p53 in tumor cells contributes to activation of the hypoxia induced angiogenic switch and tumor progression as opposed to the aects of p53 on hypoxia induced growth arrest or apoptosis.
Materials and methods
Cell culture
Mammary breast cancer cells MCF-7 and the normal human diploid ®broblast cells IMR-90 were purchased from American Type Culture Collection (Rockville, MD, USA). MCF-7 cells and IMR-90 cells were cultured in minimum essential medium and Dulbecco's modi®ed essential medium (DMEM), respectively, to subcon¯uent conditions. Media were supplemented with penicillin (100 U/ml), streptomycin (100 mg/ml), and 10% heat-inactivated fetal calf serum. r8-MCF-7 cells were generated by incubating wild-type MCF-7 cells in medium containing ethidium bromide (25 ng/ml), sodium pyruvate (1 mM) and uridine (50 mg/ml) (King and Attardi, 1996) . MCF-7 cells were transfected with 5 mg of pCMV-plasmid containing the human pappiloma virus protein E6, or neomycin control vector by electroporation at 250 V, 960 mF. Cells were selected and maintained in minimum essential medium supplemented with G418 (1 mg/ ml), penicillin (100 U/ml), streptomycin (100 mg/ml) and 10% heat-inactivated fetal calf serum. The IMR-90 cells, neo MCF-7 cells, and E6 MCF-7 cell lines were irradiated under subcon¯uent growth conditions at room temperature with 400 rad from a cesium source. Immediately after irradiation, the cells were returned to culture conditions at 378C and were sampled 18 h later for cell cycle analysis. Murine embryonic ®broblasts were a gift from Dr Celeste Simon and were cultured in DMEM supplemented with penicillin (100 U/ml), streptomycin (100 mg/ml), and 10% heat-inactivated fetal calf serum. Embryonic ventricular cardiac myocytes were prepared as described previously. Cells (0.7610 6 ) were pipetted onto coverslips, incubated, and grown into con¯uent layers. Synchronous contractions were seen by the third day in culture. Cells were maintained in culture medium consisting of 6% heat-inactivated fetal bovine serum, 40% M199, 54% balanced salt solution and penicillin (100 U/ml)/streptomycin (100 mg/ml).
Oxygen conditions
Hypoxic conditions were achieved by using a mass¯ow controller (Cameron Instruments, Port Aransas, TX, USA) to blend O 2 , CO 3 and N 2 to achieve dierent compositions. The mixed gas was humidi®ed by bubbling through distilled water and subsequently delivered to the headspace of individual 75 cm 2 T-¯asks or chambers that accommodate petri dishes. The¯asks and chambers have stoppers containing an inlet for the mixed gas and an outlet port. The¯asks and chambers were gently agitated to promote equilibration of the head space gas with the media bathing the cells. The oscillating platform and¯asks were maintained in a 378C incubator. Oxygen tensions were con®rmed using a polarographic electrode in contact with the stirred media.
Measurement of reactive oxygen species
ROS generation in cells was assessed using the probe 2',7'-dichloro¯uorescin diacetate (DCFH-DA, 5 mM) (Molecular Probes). ROS in the cells oxidize DCFH, yielding thē uorescent product 2',7'-dichloro¯uorescein (DCF). Cells were plated on petri dishes and incubated with DCFH-DA (10 mM) under various conditions. Subsequently, the media was removed, cells were lysed and centrifuged to remove debris, and the¯uorescence was measured. Fluorescence was measured using a spectro¯uorometer at an excitation wavelength of 500 nm and emission wavelength 530 nm. Data were normalized to values obtained from normoxic untreated samples. 
Preparation of nuclear extracts
Immunoblotting
Thirty mg of nuclear extract was mixed with equal volume of electrophoresis buer (1.0 ml glycerol, 0.5 ml b-mercaptoethanol, 3.0 ml 10% SDS, 1.25 ml 1.0 M Tris-HCl, pH=6.7 and 1 ± 2 mg bromophenol blue). After heating, the protein was resolved on a 10 or 12% polyacrilymide-SDS gel and transferred to hybond ECL nitrocellulose paper (Amersham). After transfer, the gel was stained with ponceau stain to verify uniform loading and transfer. Membranes were blocked with 5% milk in TBS-T (Tris-HCL (10 mM), NaCl (150 mM), 0.1% Tween-20, pH=8.0). Subsequently, membranes were incubated with the p53 antibody (AB-1; Oncogene Science) or WAF1 (AB-1; Oncogene Science) overnight at 48C. Chick cardiac myocyte p53 protein levels were detected using the p53 antibody (PAB240 clone, Boehringer Mannheim). The membrane was washed with TBS-T three times and incubated for 1 h at room temperature with horseradish peroxidase-conjugated secondary antibody. Subsequently, the membrane was washed three times with TBS-T and analysed by enhanced chemiluminescence (Amersham).
Electrophoretic mobility shift assay
Gel shift assays were performed as previously described (Graeber et al., 1994) . The DNA binding reactions were performed at room temperature in buer containing HEPES (20 mM), KCl (100 mM), EDTA (1 mM), DTT (1 mM), 1 mg calf thymus DNA, 50 000 d.p.m. of labeled probe, 10% glycerol, and 15 mg of nuclear extracts in a volume of 25 ml at pH=7.8. The duplex oligonucleotide probe used in the binding reactions was the sequence 5'-GGA-CATGCCCGGGCAT-3'. The probe was labeled with a-32 PdGTP (800 Ci/mol) and a-32 P-dCTP (800 Ci/mol) by the klenow polymerase. Unincorporated nucleotides were separated using Quick Spin sephadex G-50 columns (Boehringer Mannheim). The p53-speci®c antibody AB-1 (200 ng; Oncogene Science) was included in the reactions to enhance the detection of p53-DNA complexes. All reaction mixtures were electrophoresed on 4% nondenaturing polyacrilymide gel. Subsequently, the gels were dried and autoradiographed.
Cell cycle and viability analysis
Cell cycle distribution was determined by DNA content. DNA content was assessed by ®xing cells in 70% ethanol. After ®xation, cells were resuspended in 3.8 mM sodium citrate, 0.125 mg/ml RNase A, 0.1 mg/ml propidium iodide incubated for 1 h and analysed by¯ow cytometry. Cell number was determined using a hemacytometer. Cell viability was assessed by Trypan blue or propidium iodide (PI, 5 mM, Molecular Probes). P.I. staining was assessed in cardiac myocytes plated on petri dishes and¯uorescence was determined using an inverted microscope equipped with a 12-bit digital camera.
